Author:
Gebremariam Guesh,Kiros Mulugeta,Hagos Selemun,Hadush Haftom,Gebremichael Amaha,Gebrekirstos Gebretsadkan,Tesfay Aregawi,Gebrewahid Teumelsan,Berihu Tesfay,Gebremariam Brhane
Abstract
Abstract
Background
Tuberculosis (TB) is a major public health concern in the developing countries. Moreover, the emergence of multidrug-resistant tuberculosis is challenging. However, there are no organized data on the trends of pulmonary tuberculosis and rifampicin-resistant Mycobacterium tuberculosis in the study area.
Methods
A retrospective cross-sectional study was conducted to fill the information gap in Central Tigray at St. Mary General Hospital between 2018 and 2023. Data were collected from the GeneXpert™ tuberculosis registration logbooks using standard checklists and analyzed using Statistical Package for Social Science version 22. After performing logistic regression, a p-value < 0.05 with a corresponding 95% confidence interval was considered statistically significant. Moreover, chi square test for trend was performed to assess the percentage of annual detection of pulmonary tuberculosis and rifampicin-resistant Mycobacterium tuberculosis during the study years.
Result
Presumptive pulmonary tuberculosis patients with complete data (n = 3696) were included in the study. The overall prevalence of pulmonary tuberculosis was 11.7%, of which 8.1% were resistant to rifampicin. The study revealed that the incidence of pulmonary tuberculosis has been increasing, mainly in the recent four years. Likewise, an increase in rifampicin-resistant Mycobacterium tuberculosis was observed with considerable fluctuations. Age, human immunodeficiency virus infection, and presumptive rifampicin-resistant Mycobacterium tuberculosis infection were significantly associated with the presence of pulmonary tuberculosis. Moreover, pulmonary tuberculosis was more prevalent among participants in the productive-age group.
Conclusion
Although there have been fluctuations, an increasing of pulmonary tuberculosis and rifampicin-resistant Mycobacterium tuberculosis has been observed in recent years. Hence, prevention and treatment strategies for tuberculosis should be strengthened to alleviate the burden of pulmonary tuberculosis and rifampicin-resistant Mycobacterium tuberculosis in the study area.
Publisher
Springer Science and Business Media LLC
Reference47 articles.
1. Van Soolingen D. Molecular epidemiology of tuberculosis and other mycobacterial infections: main methodologies and achievements. J Int Med. 2001;249(1):1–26.
2. Lee SH. Tuberculosis infection and latent tuberculosis. Tuberc Respir Dis. 2016;79(4):201–6.
3. Thorson A, Diwan VK. Gender inequalities in tuberculosis: aspects of infection, notification rates, and compliance. Curr Opin Pulm Med. 2001;7(3):165–9.
4. National Department of Health. National Tuberculosis Management Guidelines 2014. TB DOTS Strategy Coordination, National Department of Health. Department of Health, Republic of South Africa 2014. https://knowledgehub.health.gov.za/elibrary/nationaltuberculosis-management-guidelines. Accessed May 2023.
5. Centers of Disease control and prevention (CDC). Basic TB facts. March 20, 2016. http://medbox.iiab.me/modules/encdc/www.cdc.gov/tb/topic/basics/default.htm. Accessed May 2023.